MONOVISC SYRINGE
Sterile, apyrogenic solution based on slightly cross-linked sodium hyaluronate with a proprietary chemical binder. Contains 22 mg/ml of slightly cross-linked sodium hyaluronate (NaHA) dissolved in a physiologically osmolar buffered saline solution. It is composed of high molecular weight, ultrapure sodium hyaluronate, produced by bacterial fermentation. Hyaluronic acid is a complex natural polysaccharide from the glycosaminoglycan family.
– It is indicated as a viscoelastic supplement or substitute for synovial fluid in human joints.
– It is suitable for the treatment of symptoms of dysfunctions of human joints such as osteoarthritis.
The actions performed by the product are: lubrication and mechanical support.
Method of use
Inject the required amount of product through a suitable diameter sterile, single-use hypodermic needle into the selected joint space. The sterile needle must be attached to the Monovisc syringe by medical personnel, using aseptic techniques approved by the clinical center. The most used diameters for knee injections are gauges 18-21. The final selection for any procedure must be determined by the physician. Before injecting the product, the physician must ensure that penetration into the joint synovial space is adequate.
Store at a temperature between 2° – 25°C. Protect from freezing.
